{"transactions":[{"id":4639279,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-13T20:05:16.000Z","date":"2026-10-09","kind":"sale","planned":false,"acquired":false,"shares":2462,"price":156.3049,"value":384822.6638,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":98114,"source":{"system":"sec-edgar","filing":"0001214659-26-012823","document":"marketforms-74129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827198/000121465926012823/marketforms-74129.xml","form_type":"4"}},{"id":4629729,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-05T20:05:24.000Z","date":"2026-10-02","kind":"sale","planned":false,"acquired":false,"shares":8057,"price":188.884,"value":1521838.388,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":100576,"source":{"system":"sec-edgar","filing":"0001214659-26-012549","document":"marketforms-74097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827198/000121465926012549/marketforms-74097.xml","form_type":"4"}},{"id":675848,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-25T20:05:16.000Z","date":"2026-08-21","kind":"sale","planned":false,"acquired":false,"shares":1965,"price":139.066,"value":273264.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":108633,"source":{"system":"sec-edgar","filing":"0001214659-26-010829","document":"marketforms-73879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465926010829/marketforms-73879.xml","form_type":"4"}},{"id":710463,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-13T20:05:08.000Z","date":"2026-07-09","kind":"sale","planned":false,"acquired":false,"shares":2399,"price":94.334,"value":226307.266,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":110276,"source":{"system":"sec-edgar","filing":"0001214659-26-008480","document":"marketforms-73600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465926008480/marketforms-73600.xml","form_type":"4"}},{"id":754096,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:05:30.000Z","date":"2026-05-29","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":70,"value":280000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 8, 2025."}],"balance_after":112675,"source":{"system":"sec-edgar","filing":"0001214659-26-007029","document":"marketforms-73321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465926007029/marketforms-73321.xml","form_type":"4"}},{"id":763243,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-26T20:05:13.000Z","date":"2026-05-21","kind":"sale","planned":false,"acquired":false,"shares":2019,"price":53.257,"value":107525.883,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":116675,"source":{"system":"sec-edgar","filing":"0001214659-26-006712","document":"marketforms-73244.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465926006712/marketforms-73244.xml","form_type":"4"}},{"id":803525,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-21T20:05:10.000Z","date":"2026-04-17","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":60,"value":240000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 8, 2025."}],"balance_after":118694,"source":{"system":"sec-edgar","filing":"0001214659-26-004893","document":"marketforms-72950.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465926004893/marketforms-72950.xml","form_type":"4"}},{"id":806848,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-16T20:05:07.000Z","date":"2026-04-14","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":55,"value":165000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 8, 2025."}],"balance_after":122694,"source":{"system":"sec-edgar","filing":"0001214659-26-004735","document":"marketforms-72938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465926004735/marketforms-72938.xml","form_type":"4"}},{"id":809487,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-13T20:05:14.000Z","date":"2026-04-09","kind":"sale","planned":false,"acquired":false,"shares":2597,"price":49.889,"value":129561.733,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":125694,"source":{"system":"sec-edgar","filing":"0001214659-26-004601","document":"marketforms-72923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465926004601/marketforms-72923.xml","form_type":"4"}},{"id":881408,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-25T21:05:17.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":2085,"price":46.7098,"value":97389.933,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":128291,"source":{"system":"sec-edgar","filing":"0001214659-26-002442","document":"marketforms-72310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465926002442/marketforms-72310.xml","form_type":"4"}},{"id":904671,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-13T22:10:38.000Z","date":"2026-02-12","kind":"sale","planned":true,"acquired":false,"shares":7000,"price":50,"value":350000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 8, 2025."}],"balance_after":130031,"source":{"system":"sec-edgar","filing":"0001214659-26-001737","document":"marketforms-72137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465926001737/marketforms-72137.xml","form_type":"4"}},{"id":938314,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-15T21:13:44.000Z","date":"2026-01-13","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":40,"value":120000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 8, 2025."}],"balance_after":137031,"source":{"system":"sec-edgar","filing":"0001214659-26-000509","document":"marketforms-71849.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465926000509/marketforms-71849.xml","form_type":"4"}},{"id":939911,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-13T21:05:05.000Z","date":"2026-01-09","kind":"sale","planned":false,"acquired":false,"shares":2738,"price":35.261,"value":96544.618,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":140031,"source":{"system":"sec-edgar","filing":"0001214659-26-000423","document":"marketforms-71821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465926000423/marketforms-71821.xml","form_type":"4"}},{"id":988369,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-25T21:05:17.000Z","date":"2025-11-21","kind":"sale","planned":false,"acquired":false,"shares":887,"price":26.5035,"value":23508.6045,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":142769,"source":{"system":"sec-edgar","filing":"0001214659-25-017219","document":"marketforms-71345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465925017219/marketforms-71345.xml","form_type":"4"}},{"id":992290,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-20T21:05:19.000Z","date":"2025-11-18","kind":"grant","planned":false,"acquired":true,"shares":32648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award (\"RSU\") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 20, 2025 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":143656,"source":{"system":"sec-edgar","filing":"0001214659-25-017001","document":"marketforms-71305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465925017001/marketforms-71305.xml","form_type":"4"}},{"id":1009414,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-03T21:05:08.000Z","date":"2025-10-30","kind":"sale","planned":false,"acquired":false,"shares":5517,"price":31.4443,"value":173478.2031,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units (\"PSUs\"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":111008,"source":{"system":"sec-edgar","filing":"0001214659-25-015763","document":"marketforms-71186.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465925015763/marketforms-71186.xml","form_type":"4"}},{"id":1011197,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-30T20:05:09.000Z","date":"2025-10-28","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Performance Stock Units for which target criteria was determined to have been met on October 28, 2025. 60% of the PSUs remain subject to time-based vesting and will vest on October 1, 2026, subject to continued service or acceleration of vesting as provided in the award agreement."}],"balance_after":116525,"source":{"system":"sec-edgar","filing":"0001214659-25-015583","document":"marketforms-71172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465925015583/marketforms-71172.xml","form_type":"4"}},{"id":1019911,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-10T20:05:09.000Z","date":"2025-10-09","kind":"sale","planned":true,"acquired":false,"shares":2517,"price":32.922,"value":82864.674,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":91525,"source":{"system":"sec-edgar","filing":"0001214659-25-014856","document":"marketforms-71020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465925014856/marketforms-71020.xml","form_type":"4"}},{"id":1019910,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-10T20:05:09.000Z","date":"2025-10-08","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":31.15,"value":93450.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 8, 2025."}],"balance_after":94042,"source":{"system":"sec-edgar","filing":"0001214659-25-014856","document":"marketforms-71020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465925014856/marketforms-71020.xml","form_type":"4"}},{"id":1021270,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-08T20:05:18.000Z","date":"2025-10-06","kind":"sale","planned":false,"acquired":false,"shares":5875,"price":32.187,"value":189098.625,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units (\"PSUs\"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":97042,"source":{"system":"sec-edgar","filing":"0001214659-25-014777","document":"marketforms-70992.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465925014777/marketforms-70992.xml","form_type":"4"}},{"id":1056585,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-25T20:05:24.000Z","date":"2025-08-21","kind":"sale","planned":false,"acquired":false,"shares":918,"price":25.964,"value":23834.952,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":102917,"source":{"system":"sec-edgar","filing":"0001214659-25-012706","document":"marketforms-70340.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465925012706/marketforms-70340.xml","form_type":"4"}},{"id":1088452,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-11T20:05:15.000Z","date":"2025-07-09","kind":"sale","planned":false,"acquired":false,"shares":2449,"price":38.146,"value":93419.554,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":103569,"source":{"system":"sec-edgar","filing":"0001214659-25-010310","document":"marketforms-70077.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465925010310/marketforms-70077.xml","form_type":"4"}},{"id":1134796,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-23T20:05:12.000Z","date":"2025-05-21","kind":"sale","planned":false,"acquired":false,"shares":936,"price":29.747,"value":27843.192,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":106018,"source":{"system":"sec-edgar","filing":"0001214659-25-008296","document":"marketforms-69628.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465925008296/marketforms-69628.xml","form_type":"4"}},{"id":1173149,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-11T20:05:14.000Z","date":"2025-04-09","kind":"sale","planned":false,"acquired":false,"shares":2542,"price":34.9674,"value":88887.1308,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":106954,"source":{"system":"sec-edgar","filing":"0001214659-25-005780","document":"marketforms-69137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465925005780/marketforms-69137.xml","form_type":"4"}},{"id":1245254,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-25T21:05:11.000Z","date":"2025-02-21","kind":"sale","planned":false,"acquired":false,"shares":918,"price":44.177,"value":40554.486,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":109496,"source":{"system":"sec-edgar","filing":"0001214659-25-003435","document":"marketforms-68343.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465925003435/marketforms-68343.xml","form_type":"4"}},{"id":1303174,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-14T21:05:06.000Z","date":"2025-01-10","kind":"sale","planned":false,"acquired":false,"shares":5886,"price":43.263,"value":254646.018,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":110096,"source":{"system":"sec-edgar","filing":"0001214659-25-000554","document":"marketforms-67833.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465925000554/marketforms-67833.xml","form_type":"4"}},{"id":1340157,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-06T21:05:18.000Z","date":"2024-12-04","kind":"grant","planned":false,"acquired":true,"shares":26745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award (\"RSU\") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 20, 2024 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":115982,"source":{"system":"sec-edgar","filing":"0001214659-24-020031","document":"marketforms-67496.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465924020031/marketforms-67496.xml","form_type":"4"}},{"id":1363273,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-15T21:05:15.000Z","date":"2024-11-06","kind":"sale","planned":false,"acquired":false,"shares":4160,"price":44.605,"value":185556.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units (\"PSUs\"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":89237,"source":{"system":"sec-edgar","filing":"0001214659-24-019254","document":"marketforms-67368.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465924019254/marketforms-67368.xml","form_type":"4/A","original_submission_date":"2024-11-08"}},{"id":1370964,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-08T21:05:19.000Z","date":"2024-11-06","kind":"sale","planned":false,"acquired":false,"shares":4160,"price":44.605,"value":185556.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units (\"PSUs\") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e)."}],"balance_after":89237,"source":{"system":"sec-edgar","filing":"0001214659-24-018614","document":"marketforms-67292.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465924018614/marketforms-67292.xml","form_type":"4"}},{"id":1373978,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-06T22:05:39.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units for which target criteria was determined to have been met on November 4, 2024. 60% of the PSUs remain subject to time-based vesting and will vest on October 1,2025, subject to continued service or acceleration of vesting as provided in the award agreement."}],"balance_after":93397,"source":{"system":"sec-edgar","filing":"0001214659-24-018498","document":"marketforms-67275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465924018498/marketforms-67275.xml","form_type":"4"}},{"id":1387455,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-11T20:05:10.000Z","date":"2024-10-09","kind":"sale","planned":false,"acquired":false,"shares":856,"price":41.812,"value":35791.072,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":73397,"source":{"system":"sec-edgar","filing":"0001214659-24-017482","document":"marketforms-67154.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465924017482/marketforms-67154.xml","form_type":"4"}},{"id":1455861,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-11T20:05:05.000Z","date":"2024-07-09","kind":"sale","planned":false,"acquired":false,"shares":842,"price":48.913,"value":41184.746,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":73602,"source":{"system":"sec-edgar","filing":"0001214659-24-012259","document":"marketforms-66532.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465924012259/marketforms-66532.xml","form_type":"4"}},{"id":1542975,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-11T20:05:15.000Z","date":"2024-04-09","kind":"sale","planned":false,"acquired":false,"shares":556,"price":33.155,"value":18434.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":74444,"source":{"system":"sec-edgar","filing":"0001214659-24-006630","document":"marketforms-65528.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465924006630/marketforms-65528.xml","form_type":"4"}},{"id":1681370,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-10T21:05:25.000Z","date":"2024-01-08","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a restricted stock unit award (\"RSU\") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of January 8, 2024 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001214659-24-000566","document":"marketforms-63909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465924000566/marketforms-63909.xml","form_type":"4"}},{"id":1681369,"issuer":{"id":3619,"kind":"organization","name":"Twist Bioscience Corp","symbol":"TWST"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-10T21:05:25.000Z","date":"2024-01-08","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1/4th of the Total Number of Shares subject to the RSUs shall vest on the 1-year anniversary of the Vesting Commencement Date, and 1/16th of the total number of shares subject to the RSUs shall vest on each quarter anniversary (or on the last day of the on the month if no such day exists) thereafter, for a total vesting period of 48 months."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001214659-24-000566","document":"marketforms-63909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1581280/000121465924000566/marketforms-63909.xml","form_type":"4"}},{"id":1730724,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-22T16:15:14.000Z","date":"2023-11-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":33,"price":2.6,"value":85.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This sale was effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2023."}],"balance_after":258,"source":{"system":"sec-edgar","filing":"0001209191-23-056456","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000120919123056456/doc4.xml","form_type":"4"}},{"id":1735980,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-17T16:15:21.000Z","date":"2023-11-17","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":19,"price":2.56,"value":48.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the number of shares of Common Stock that were sold to satisfy tax withholding requirements on vesting of restricted stock units pursuant to the Issuer's automatic sell to cover program, and does not represent a discretionary sale by the Reporting Person."}],"balance_after":291,"source":{"system":"sec-edgar","filing":"0001209191-23-055740","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000120919123055740/doc4.xml","form_type":"4"}},{"id":1735979,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-17T16:15:21.000Z","date":"2023-11-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2842,"price":2.55,"value":7247.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This sale was effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2023."}],"balance_after":310,"source":{"system":"sec-edgar","filing":"0001209191-23-055740","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000120919123055740/doc4.xml","form_type":"4"}},{"id":1802845,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-17T16:10:57.000Z","date":"2023-08-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":824,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F9","text":"On January 17, 2023, the Issuer effected a 1-for-20 reverse stock split of its Common Stock (the \"Reverse Stock Split\"). These securities reflect the Reverse Stock Split."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Issuer cancelled the Stock Option in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The Stock Option shall vest and become exercisable with respect to 16 quarterly installments commencing on February 15, 2021, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date."}],"balance_after":0,"derivative":{"exercise_price":1051.6,"expiration_date":"2031-01-28","underlying":"Common Stock","underlying_shares":824},"source":{"system":"sec-edgar","filing":"0001209191-23-046243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000120919123046243/doc4.xml","form_type":"4"}},{"id":1802844,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-17T16:10:57.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":824,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Issuer cancelled the Stock Option in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The Stock Option shall vest and become exercisable with respect to 16 quarterly installments commencing on February 15, 2021, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date."}],"balance_after":824,"derivative":{"exercise_price":3.305,"expiration_date":"2031-01-28","underlying":"Common Stock","underlying_shares":824},"source":{"system":"sec-edgar","filing":"0001209191-23-046243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000120919123046243/doc4.xml","form_type":"4"}},{"id":1802843,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-17T16:10:57.000Z","date":"2023-08-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":82500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Issuer cancelled the Stock Option in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Stock Option vests and becomes exercisable in full upon attainment of a 360-day VWAP (volume-weighted average price) of $20.00 for the Issuer's Common Stock on or prior to February 15, 2028, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through such date."}],"balance_after":0,"derivative":{"exercise_price":11.58,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001209191-23-046243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000120919123046243/doc4.xml","form_type":"4"}},{"id":1802842,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-17T16:10:57.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":82500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Issuer cancelled the Stock Option in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Stock Option vests and becomes exercisable in 8 equal quarterly installments, with the first installment vesting on November 15, 2023, provided, that, any unvested portion of the Stock Option shall vest and become exercisable upon attainment of a 360-day VWAP (volume weighted average price) of $20.00 for the Issuer's Common Stock, in either case, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date."}],"balance_after":82500,"derivative":{"exercise_price":3.305,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001209191-23-046243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000120919123046243/doc4.xml","form_type":"4"}},{"id":1802841,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-17T16:10:57.000Z","date":"2023-08-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":82500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Issuer cancelled the Stock Option in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Stock Option vests and becomes exercisable as to 20% of the shares subject to the stock option on February 15, 2024 (the \"Vesting Start Date\"), with the remainder vesting in 16 equal quarterly installments thereafter until all of the shares subject to the stock option have vested and become exercisable on the fourth anniversary of the Vesting Start Date, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date."}],"balance_after":0,"derivative":{"exercise_price":11.58,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001209191-23-046243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000120919123046243/doc4.xml","form_type":"4"}},{"id":1802840,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-17T16:10:57.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":82500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Issuer cancelled the Stock Option in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option vests and becomes exercisable in 8 equal quarterly installments, with the first installment vesting on November 15, 2023, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date."}],"balance_after":82500,"derivative":{"exercise_price":3.305,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001209191-23-046243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000120919123046243/doc4.xml","form_type":"4"}},{"id":1802839,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-17T16:10:57.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":97500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option vests and becomes exercisable in 8 equal quarterly installments, with the first installment vesting on November 15, 2023, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date."}],"balance_after":97500,"derivative":{"exercise_price":3.305,"expiration_date":"2033-08-14","underlying":"Common Stock","underlying_shares":97500},"source":{"system":"sec-edgar","filing":"0001209191-23-046243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000120919123046243/doc4.xml","form_type":"4"}},{"id":1802838,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-17T16:10:57.000Z","date":"2023-08-17","kind":"sale","planned":false,"acquired":false,"shares":19,"price":3.2353,"value":61.4707,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the number of shares of Common Stock that were sold to satisfy tax withholding requirements on vesting of restricted stock units pursuant to the Issuer's automatic sell to cover program, and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $3.23 to $3.24, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission full information regarding the shares of Common Stock sold at each separate price within the range set forth in this footnote."}],"balance_after":3152,"source":{"system":"sec-edgar","filing":"0001209191-23-046243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000120919123046243/doc4.xml","form_type":"4"}},{"id":1886410,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-18T16:05:30.000Z","date":"2023-05-17","kind":"sale","planned":false,"acquired":false,"shares":19,"price":4.6901,"value":89.1119,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the number of shares of Common Stock that were sold to satisfy tax withholding requirements on vesting of restricted stock units pursuant to the Issuer's automatic sell to cover program, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees."}],"balance_after":3171,"source":{"system":"sec-edgar","filing":"0001209191-23-030591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000120919123030591/doc4.xml","form_type":"4"}},{"id":1998477,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-22T16:12:22.000Z","date":"2023-02-17","kind":"sale","acquired":false,"shares":21,"price":7.3701,"value":154.7721,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the number of shares of Common Stock that were sold to satisfy tax withholding requirements on vesting of restricted stock units pursuant to the Issuer's automatic sell to cover program, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On January 17, 2023, the Issuer effected a 1-for-20 reverse stock split of its Common Stock (the \"Reverse Stock Split\"). These securities reflect the Reverse Stock Split."}],"balance_after":3190,"source":{"system":"sec-edgar","filing":"0001209191-23-011623","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000120919123011623/doc4.xml","form_type":"4"}},{"id":2031972,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T16:09:23.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":82500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests and becomes exercisable in full upon attainment of a 360-day VWAP (volume-weighted average price) of $20.00 for the Issuer's Common Stock on or prior to February 15, 2028, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through such date."}],"balance_after":82500,"derivative":{"exercise_price":11.58,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001209191-23-006789","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000120919123006789/doc4.xml","form_type":"4"}},{"id":2031971,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T16:09:23.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":82500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option vests and becomes exercisable as to 20% of the shares subject to the stock option on February 15, 2024 (the \"Vesting Start Date\"), with the remainder vesting in 16 equal quarterly installments thereafter until all of the shares subject to the stock option have vested and become exercisable on the fourth anniversary of the Vesting Start Date, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date."}],"balance_after":82500,"derivative":{"exercise_price":11.58,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001209191-23-006789","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000120919123006789/doc4.xml","form_type":"4"}},{"id":2104011,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Subscription Rights (right to buy)","published_at":"2022-11-25T13:05:18.000Z","date":"2022-11-22","kind":"other","acquired":true,"shares":525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents exercise price per whole share of Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Rights Offering expired on November 17, 2022, and final determination of the pro rata allocation for each exercising holder was determined on November 22, 2022."}],"balance_after":0,"derivative":{"exercise_price":0.5,"exercise_date":"2022-10-31","underlying":"Common Stock","underlying_shares":4995},"source":{"system":"sec-edgar","filing":"0000899243-22-037000","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000089924322037000/doc4.xml","form_type":"4"}},{"id":2104010,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-25T13:05:18.000Z","date":"2022-11-22","kind":"other","acquired":true,"shares":4995,"price":0.5,"value":2497.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's Common Stock acquired by the Reporting Person following the exercise of his basic subscription rights in connection with the Issuer's rights offering to holders of Common Stock, as described in the issuer's prospectus dated October 27, 2022 (the \"Rights Offering\"). Each holder of Common Stock of record as of October 24, 2022 received one right for each share of Common Stock, and each right entitled the holder of Common Stock to purchase 9.5151 shares of Common Stock at the subscription price of $0.50 per whole share."}],"balance_after":64222,"source":{"system":"sec-edgar","filing":"0000899243-22-037000","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000089924322037000/doc4.xml","form_type":"4"}},{"id":2108170,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-21T17:52:21.000Z","date":"2022-11-17","kind":"sale","acquired":false,"shares":687,"price":0.5192,"value":356.6904,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the number of shares of Common Stock that were sold to satisfy tax withholding requirements on vesting of restricted stock units pursuant to the Issuer's automatic sell to cover program, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $0.5114 to $0.5256, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission full information regarding the shares of Common Stock sold at each separate price within the range set forth in this footnote."}],"balance_after":59227,"source":{"system":"sec-edgar","filing":"0000899243-22-036555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000089924322036555/doc4.xml","form_type":"4"}},{"id":2171416,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-29T20:36:27.000Z","date":"2022-08-15","kind":"tax_withholding","acquired":false,"shares":357,"price":1.14,"value":406.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Constitute Restricted Stock Units that were withheld to satisfy tax liabilities arising from the settlement of vested Restricted Stock Units."}],"balance_after":59914,"source":{"system":"sec-edgar","filing":"0000899243-22-030017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000089924322030017/doc4.xml","form_type":"4"}},{"id":2171415,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-29T20:36:27.000Z","date":"2022-05-31","kind":"tax_withholding","acquired":false,"shares":714,"price":1.55,"value":1106.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Constitute Restricted Stock Units that were withheld to satisfy tax liabilities arising from the settlement of vested Restricted Stock Units."}],"balance_after":60271,"source":{"system":"sec-edgar","filing":"0000899243-22-030017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000089924322030017/doc4.xml","form_type":"4"}},{"id":2171414,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-29T20:36:27.000Z","date":"2022-03-09","kind":"tax_withholding","acquired":false,"shares":423,"price":4.01,"value":1696.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Constitute Restricted Stock Units that were withheld to satisfy tax liabilities arising from the settlement of vested Restricted Stock Units."}],"balance_after":60985,"source":{"system":"sec-edgar","filing":"0000899243-22-030017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000089924322030017/doc4.xml","form_type":"4"}},{"id":2171413,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-29T20:36:27.000Z","date":"2022-03-09","kind":"disposition_to_issuer","acquired":false,"shares":608,"price":4.01,"value":2438.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Constitute vested Restricted Stock Units that were settled in cash."}],"balance_after":61408,"source":{"system":"sec-edgar","filing":"0000899243-22-030017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000089924322030017/doc4.xml","form_type":"4"}},{"id":2595748,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-19T17:46:23.000Z","date":"2021-08-17","kind":"tax_withholding","acquired":false,"shares":359,"price":24.5373,"value":8808.8907,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld so that the Reporting Person could satisfy tax liability arising from the release of vested Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold.  The actual sale prices range from $24.4601 to $24.6650 per share.  Information on the actual number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the adjusted total which includes an aggregate of 1,807 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":62016,"source":{"system":"sec-edgar","filing":"0000899243-21-033683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000089924321033683/doc4.xml","form_type":"4"}},{"id":2647076,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T17:32:44.000Z","date":"2021-06-29","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is partially vested and shall vest and become exercisable with respect to 25% of the shares subject to the stock option on the first anniversary of June 3, 2019 (the \"Vesting Start Date\") and one forty-eighth (1/48th) of the shares of subject to the option shall vest and become exercisable on each monthly anniversary thereafter until all of the shares subject to the stock option have vested and became exercisable on the fourth anniversary of the Vesting Start Date, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Vesting Start Date, vesting schedule and the expiration date were previously misreported in a Form 3 filed on October 15, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Vesting Start Date, vesting schedule and the expiration date were previously misreported in a Form 3 filed on October 15, 2020."}],"balance_after":133692,"derivative":{"exercise_price":2.55,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-21-026983","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000089924321026983/doc4.xml","form_type":"4"}},{"id":2647075,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-07-01T17:32:44.000Z","date":"2021-06-29","kind":"sale","acquired":false,"shares":10000,"price":38.43,"value":384300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":60568,"source":{"system":"sec-edgar","filing":"0000899243-21-026983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000089924321026983/doc4.xml","form_type":"4"}},{"id":2647074,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-07-01T17:32:44.000Z","date":"2021-06-29","kind":"exercise","acquired":true,"shares":10000,"price":2.55,"value":25500.0,"ownership":{"direct":true},"balance_after":70568,"source":{"system":"sec-edgar","filing":"0000899243-21-026983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000089924321026983/doc4.xml","form_type":"4"}},{"id":2704731,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-19T17:10:26.000Z","date":"2021-05-17","kind":"tax_withholding","acquired":false,"shares":362,"price":33.9849,"value":12302.5338,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld so that the Reporting Person could satisfy tax liability arising from the release of vested Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold.  The actual sale prices range from $33.86 to $34.07 per share.  Information on the actual number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":60568,"source":{"system":"sec-edgar","filing":"0000899243-21-019950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000089924321019950/doc4.xml","form_type":"4"}},{"id":2878684,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-04T21:47:26.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest and become exercisable with respect to 16 quarterly installments commencing on February 15, 2021, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date."}],"balance_after":16500,"derivative":{"exercise_price":52.58,"expiration_date":"2031-01-28","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0000899243-21-004982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000089924321004982/doc4.xml","form_type":"4"}},{"id":2878683,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-04T21:47:26.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") which vest in 16 quarterly installments commencing on February 15, 2021, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date. Each RSU represents a contingent right to receive one (1) share of common stock of the Issuer."}],"balance_after":60930,"source":{"system":"sec-edgar","filing":"0000899243-21-004982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000089924321004982/doc4.xml","form_type":"4"}},{"id":3001221,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series E Preferred Stock","published_at":"2020-10-22T18:47:28.000Z","date":"2020-10-20","kind":"exercise","acquired":false,"shares":11097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series E Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series E Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series E Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11097},"source":{"system":"sec-edgar","filing":"0000899243-20-029067","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000089924320029067/doc4.xml","form_type":"4"}},{"id":3001220,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":19815,"kind":"person","name":"Laponis Adam","position":1,"cik":"0001827198","reported_name":"Laponis Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-22T18:47:28.000Z","date":"2020-10-20","kind":"exercise","acquired":true,"shares":11097,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series E Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."}],"balance_after":44430,"source":{"system":"sec-edgar","filing":"0000899243-20-029067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719395/000089924320029067/doc4.xml","form_type":"4"}}]}